earnings
confidence high
sentiment positive
materiality 0.75
LifeStance Q3 revenue $363.8M (+16% YoY), net income $1.1M; raises FY2025 adjusted EBITDA guidance to $146-152M
LifeStance Health Group, Inc.
- Revenue $363.8M vs $312.7M YoY (+16%); net income $1.1M vs net loss of $6.0M.
- Adjusted EBITDA $40.2M, up 31% YoY; margin 11.1% vs 9.8%.
- Clinician base grew 11% to 7,996; visit volumes +17% to 2.3M.
- FY2025 guidance raised: Center Margin $448-462M, Adjusted EBITDA $146-152M.
- Free cash flow positive $17.0M; cash balance $203.9M.